Golden Arrow Merger Corp.
We intend to initially focus our search on identifying a prospective target business in the healthcare or healthcare-related infrastructure industries in the United States and other developed countries.
Timothy Babich serves as our CEO and CFO. Mr. Babich founded and manages Nexxus Holdings, an investment firm primarily dedicated to managing his investments. Nexxus opportunistically invests in private and public investments. At Nexxus, in late 2020, Mr. Babich merged two Ambulatory Surgery Center (ASC) software businesses, HST and Casetabs, and was personally the largest shareholder of Casetabs. The combination created the leading modern software suite for the fast-growing ASC market. Mr. Babich also is the co-founder of the RUNX1 Research Program, a medical foundation dedicated to finding a cure for an inherited predisposition to leukemia.
Jacob Doft, the chairman of our board of directors, is the co-founder and CEO of Highline Capital Management.
(Note: Golden Arrow Merger Corp. priced its SPAC IPO on March 16, 2021, in line with the terms in its prospectus: 25 million units at $10 each to raise $250 million.)
|Address||10 E. 53rd Street, 13th Floor New York, NY 10022|
|Phone Number||(212) 430-2214|
|View Prospectus:||Golden Arrow Merger Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$250.0 mil|
|Manager / Joint Managers||BTIG|
|Expected To Trade:||3/17/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|